65 filings
8-K
CDXI
Cardax, Inc.
11 Aug 21
Cardax Voluntarily Suspends SEC Reporting Obligations
5:00pm
8-K
CDXI
Cardax, Inc.
1 Jul 21
Changes in Registrant's Certifying Accountant
8:00am
8-K
CDXI
Cardax, Inc.
13 Jan 21
Entry into a Material Definitive Agreement
4:59pm
8-K
CDXI
Cardax, Inc.
18 Nov 20
Regulation FD Disclosure
4:58pm
8-K
CDXI
Cardax, Inc.
15 May 20
Entry into a Material Definitive Agreement
4:01pm
8-K
qqfimrjk7mm3h
20 Mar 20
Entry into a Material Definitive Agreement
5:07pm
8-K
8yhwj5stta7t3
27 Jan 20
Entry into a Material Definitive Agreement
5:08pm
8-K
8y4 c2hddoixh
14 Jan 20
Cardax, Inc. Announces Reverse Stock Split of Common Stock
5:00pm
8-K
r3yri5
6 Dec 19
Regulation FD Disclosure
5:26pm
8-K
mljhc78awcb3qewam
8 Oct 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
bdhexk
23 Sep 19
Cardax Announces Interim Results from CHASE Clinical Trial
8:00am
8-K
9byhn5zq7 wv0
25 Jul 19
Entry into a Material Definitive Agreement
4:00pm
8-K
myjk7pszvdcycb2
25 Jan 19
Regulation FD Disclosure
8:00am
8-K
qedhokgghi36nibptg9
6 Dec 18
Submission of Matters to a Vote of Security Holders
8:00am
8-K
bkcqqy21
2 Oct 18
Cardax Launches Human Clinical Trial Targeting Cardiovascular Inflammatory Health
8:00am
8-K
n7ww6
30 Jul 18
Cardax Announces Successful Completion of Warrant Exchange Offer
12:00am
8-K
r5tmhgaj
23 Jul 18
Regulation FD Disclosure
5:00pm
8-K
nygy 9ewbx3xomht
22 Jun 18
Cardax Announces Effectiveness of Registration Statement and Commencement of Warrant Exchange Offer
1:45pm
8-K
g3wpa
13 Jun 18
Cardax Engages Industry Veteran Fred Sancilio, Ph.D. to Launch Orphan Drug Development Program
12:00am
8-K
o0l415jeu 95fnxz
1 Jun 18
Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors
8:00am